Guest Post by Meghana Shah, Gregory Kaufman, Ben Marzouk and Amber Unwala of Eversheds Sutherland

The cannabis industry is continuing to expand throughout the United States as increasingly more states, and jurisdictions legalize the use of recreational marijuana. Massachusetts legalized recreational marijuana in 2016, causing an increase in cannabis industry activity. Subsequently, the Massachusetts Secretary of State, William Galvin, and the Massachusetts Securities Division (the “Division”) announced that they will put a halt to practices within the cannabis industry that violate the state’s securities laws. On June 19, 2019, Galvin announced that the Division initiated a wide-scale sweep into businesses raising money through investments in the state’s cannabis industry.¹ The sweep aims to warn cannabis companies that they can potentially face liability for failures to follow state securities laws, including securities offering and registration requirements, as well as for providing misleading information and inadequate disclosures of conflicts of interest related to the distribution of those securities interests. Although the Massachusetts Securities Division recently announced the sweep, federal regulators had previously provided guidance in this space.

A. Regulation at the Federal Level

The Massachusetts warning to investors is similar in scope to the warnings that the Securities and Exchange Commission (SEC) and FINRA have released in the past few years. Due to the increase in a number of investor complaints related to marijuana investments, on May 16, 2014, the SEC’s Office of Investor Education and Advocacy issued an Investor Alert to warn investors about potential risks that involve investments in marijuana-related companies.² Echoing the SEC’s concerns, FINRA released its own Investor Alert, “Marijuana Stock Scams,” to warn investors of the potential for fraud in investing in marijuana related stock.³

Both FINRA’s alert and the SEC’s alert identify the same general areas for the potential scams. First, both alerts implore investors to research whether the company has registered its securities and are in compliance with the registration requirements. Second, the alerts caution the industry to be wary of scams, including companies giving investors misleading information and disclosures regarding returns and profits within the cannabis industry. Already, the SEC has suspended trading in companies whose operations relate to the marijuana industry because of questions regarding the accuracy of publicly-available information about the companies’ operations or potential illegal activity such as unlawful sales of securities and market manipulation. Similarly, FINRA has entered into settlements through Letters of Acceptance, Waiver and Consent (AWC) with member firms for similar issues involving investment scams related to cannabis.

B. The Massachusetts Sweep

The sweep announced by Secretary Galvin will examine securities offerings by cannabis businesses to determine whether the offerings have complied with state securities regulations. Issuers of unregistered securities offerings, as well as the distributors of unregistered securities offerings such as broker-dealers and investment advisors, face liability from both state and federal securities regulators.

The sweep does not, however, include a review of the cannabis products themselves. Rather, the focus is on scrutinizing general securities compliance in the cannabis industry, particularly regarding the impact on investors that may have been misled by certain sales practices.

C. The Sweep’s First Action

On the same date as the sweep announcement, Galvin’s office also brought charges against a cannabis-related company and its president for violations of the Massachusetts securities laws and regulations.⁴ The complaint alleges that the president launched a recreational cannabis cultivation facility with a plan to lease part of it to other cannabis businesses. In doing so, the president and the company illegally marketed and sold $1.3 million of unregistered securities to at least 25 Massachusetts investors, as well as other investors located outside of Massachusetts. Furthermore, the president and the company failed to verify whether the investors were “accredited”⁵ in accordance with Rule 506 under Regulation D of the Securities Act of 1933.

The complaint also alleged that the company violated the anti-fraud provisions of the Massachusetts securities laws by making misrepresentations to investors regarding the funds they provided to the company. For example, the company informed investors that the funds received from investors would be placed in escrow accounts, however, the president and the company commingled the funds with the company’s business operation expenses in violation of their explicit escrow representations.

The complaint sought rescission of the investor assets, a fine and an order permanently barring the president from the securities industry.

D. Prior Charge Against the Cannabis Industry

The Division was looking into the cannabis industry practices related to securities offerings and misleading statements before the announcement of the sweep. In April 2019, the Division filed a complaint against a registered investment advisor and its CEO, seeking to bar the advisor from the securities industry after allegedly soliciting millions of dollars from over 100 investors, despite lacking a proper license or an actual marijuana dispensary.⁶ The CEO aimed to fund medical marijuana dispensaries, which were ultimately never opened. The complaint alleged that one client gave the investment advisor $3 million, while the adviser also raised more than $8 million from other investors. The complaint stated, “[the CEO’s] entire relationship with the emerging cannabis industry has been an improvised effort to learn as he goes, utilizing client funds and firm resources to experiment. He utterly failed to uphold the fiduciary duty…and took advantage of his advisory relationship to pursue these projects.”

The CEO failed to disclose conflicts of interests when making recommendations to one high net worth client and failed to disclose key risk factors in the cannabis industry. The complaint seeks to censure the CEO and the investment advisor from registering as an investment advisor or broker-dealer in Massachusetts. It also seeks an administrative fine and restitution to get money back into the hands of the harmed investors.

E. Securities Regulatory Violations

Both enforcement actions allege multiple violations of sections of the Massachusetts Uniform Securities Act (the “Act”). More specifically, Section 101 of the Act generally prohibits untrue statements of material facts or omissions of material facts in connection with the offers, sale, or purchase of a security. This general anti-fraud statute mirrors similar prohibitions under the federal securities laws.

In addition, Section 201 of the Act governs the registration requirement for broker-dealers distributing securities and effecting securities transactions for the accounts of others. Broker-dealers effecting securities transactions must register with the state of Massachusetts, which, among other things, typically entails filing a Form BD with the Securities and Exchange Commission and notice filing the form with the Massachusetts securities regulators. Only registered broker-dealers may effect securities transactions for customers in the state of Massachusetts. The enforcement actions related to the Massachusetts sweep include violations of this broker-dealer registration requirement, as the securities interests in certain cannabis businesses were distributed by unregistered persons.

Finally, Section 301 of the Act prohibits the offer of any unregistered security. As a practical matter, securities registered under the Securities Act of 1933 are considered “federal covered securities,” and are generally exempt from the requirement to register under the Act. In this instance, the securities interests in certain cannabis businesses were not registered with either the federal or state regulators. Cannabis companies seeking to sell interests in their businesses should ensure they have complied with both federal and state securities registration requirements, which typically entail a full regulatory review of the offering in the case of a public offering.

F. Impact of the Sweep

The Massachusetts securities regulators are not alone in their concern regarding company failures to comply with complex regulatory requirements. In an interview, Galvin stated, “We’re concerned that people are attracted to these businesses, but because they’re non-banked entities, it’s very hard to determine whether they’re real or worthy of investment.”⁷

If a company is planning to sell securities or solicit investors in the cannabis industry, the company should carefully review the regulatory requirements for registering the securities, ensuring that conflicts of interests are adequately disclosed, and that there are no misleading advertisements and false representations to investors regarding the cannabis industry.

¹Press Release, William Francis Galvin Secretary of the Commonwealth, Secretary Galvin Announces Sweep of Marijuana-Related Offerings, Issues Investor Warning, (June 19, 2019).

²Investor Alert: Marijuana-Related Investments, US Securities and Exchange Commission (May 16, 2014), https://www.investor.gov/news-alerts/investor-alerts/investor-alert-marijuana-related-investments

³Investor Alert, Marijuana Stock Scams, FINRA (May 24, 2019), http://www.finra.org/investors/alerts/updated-marijuana-stock-scams.

⁴Commonwealth of Massachusetts Office of the Secretary of the Commonwealth Securities Division, Docket No. E-2018-0094, Administrative Complaint (June 19, 2019), https://www.sec.state.ma.us/sct/current/sctpositronic/190619-MSD-Complaint-Docket-No-E-2018-0094.pdf.

⁵To qualify as an “accredited investor,” Rule 501 of Regulation D requires the following: 1) an annual income exceeding $200,000, or $300,000 for joint income, or 2) a net worth exceeding $ 1 million. 17 C.F.R. § 230.501.

⁶Commonwealth of Mass. Office of the Sec. of the Commonwealth Securities Div., Docket No. E-2017-0113, Administrative Complaint (April 17, 2019), https://www.sec.state.ma.us/sct/current/sctcpmc/Administrative-Complaint-E-2017-0113.pdf.

⁷Galvin warns marijuana companies, investors over illegal offerings, Boston Globe (June 19, 2019), https://www.bostonglobe.com/news/marijuana/2019/06/19/galvin-warns-marijuana-companies-investors-over-illegal-offerings/wXkQ9gXqbaSYR1WaPlBoXN/story.html. By using the term “non-banked,” the Secretary of State was referring to the fact that, by and large, cannabis-related companies operating in accordance with the laws of their state have limited or no access to banking services.

About the authors:

Meghana Shah is a partner resident in the New York City office of Eversheds Sutherland. Meghana was integral in launching Eversheds Sutherland’s Cannabis Industry team, for which she is a co-team leader. She has experience advising a variety of clients in the cannabis space including ancillary service providers, insurers and others seeking to enter or expand in the space. She brings to her practice a dynamic and innovative approach that takes into account the fluid legal and business landscape in the cannabis space, ensuing a robust and meaningful partnership with clients.

Gregory Kaufman is a litigation partner in the Washington DC office of Eversheds Sutherland. He defends clients in government investigation and commercial litigation. Greg has particular experience in the commodities markets. With the commoditization of cannabis, Greg was integral in launching Eversheds Sutherland’s Cannabis Industry team, for which he is a co-team leader. His experience includes assisting clients with state and local licensing, business formation, risk management and business disputes.

Ben Marzouk is counsel in the Washington DC office of Eversheds Sutherland. He is a financial services attorney who advises broker-dealers and investment advisers on compliance with federal and state securities laws, including Securities and Exchange Commission (SEC) and Financial Industry Regulatory Authority (FINRA) rules and regulations.

Amber Unwala is an associate in the Washington DC office of Eversheds Sutherland. She focuses on an array of business and commercial litigation matters, including financial services and securities litigation and enforcement matters involving the US Securities and Exchange Commission (SEC).

Are you a cannabis industry thought leader and want to be heard? Let us know your story.

Published by NCV Newswire The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch